NRF2 is directly involved in chemo-response because its transcriptional targets are responsible for the invasive gelatinolytic activity, drug-metabolizing, and transporting ability of the cancer cells (Shi et al., 2017; Matzinger et al., 2018). The gene discussed is NFE2L2; the disease is cancer.